Guardant Health
GH
#1123
Rank
C$29.84 B
Marketcap
C$220.63
Share price
-0.37%
Change (1 day)
61.11%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report